Follow The Filings

TEM Tempus AI

Tempus AI earnings company data as of 4:47 AM ET 10/19

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TEM's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TEM insider trades
  • None no insider bought on the open market
  • $284K sold by 1 insider outside a trading plan
  • $200M sold by 10 insiders under 10b5-1 plans
  1. Thomas Edward Schoenherr CEO, Diagnostics
    Planned sale
    $874K 10,281 shares at $85.00 12% of stake
    Traded Sep 25 Filed Sep 29
    ↗
  2. Eric P Lefkofsky CEO
    Planned sale
    $19.4M 250,000 shares at $77.47 71% of stake
    Traded Sep 22 Filed Sep 24
    ↗
  3. Ryan Fukushima CEO, Data
    Planned sale
    $49K 700 shares at $70.00 4.2% of stake
    Traded Sep 16 Filed Sep 18
    ↗
  4. Andrew Polovin EVP, Chief Legal Officer
    Planned sale
    $221K 2,951 shares at $75.00 2.1% of stake
    Traded Sep 17 Filed Sep 18
    ↗
  5. Ryan M Bartolucci Chief Accounting Officer
    Planned sale
    $530K 7,062 shares at $75.00 10% of stake
    Traded Sep 17 Filed Sep 18
    ↗
  6. Eric P Lefkofsky CEO
    Planned sale
    $16.1M 200,000 shares at $80.57 20% of stake
    Traded Sep 17 Filed Sep 18
    ↗
  7. Ryan Fukushima CEO, Data
    Planned sale
    $1.9M 30,846 shares at $62.71 65% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  8. Jennifer A Doudna Director
    Planned sale
    $44K 676 shares at $65.55 2.6% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  9. David R Epstein Director
    Planned sale
    $16K 250 shares at $65.55 0.8% of stake
    Traded Sep 1 Filed Sep 3
    ↗
  10. Nadja West Director
    Planned sale
    $207K 3,000 shares at $69.00 8.6% of stake
    Traded Aug 28 Filed Sep 1
    ↗
  11. Eric P Lefkofsky CEO
    Planned sale
    $828K 11,848 shares at $69.87 7.3% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  12. Eric P Lefkofsky CEO
    Planned sale
    $16.3M 238,152 shares at $68.39 60% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  13. Thomas Edward Schoenherr CEO, Diagnostics
    Planned sale
    $189K 2,694 shares at $70.00 3% of stake
    Traded Aug 21 Filed Aug 25
    ↗
  14. Ryan Fukushima CEO, Data
    Planned sale
    $1M 14,286 shares at $70.00 23% of stake
    Traded Aug 21 Filed Aug 25
    ↗
  15. Thomas Edward Schoenherr CEO, Diagnostics
    Planned sale
    $472K 8,082 shares at $58.40 8.3% of stake
    Traded Aug 19 Filed Aug 20
    ↗

Also filed in the last 12 months, not counted as buying or selling: 30 sales to cover taxes, 20 stock grants, and 6 gifts.

SEC filings

Recent issuer filings from EDGAR, 6 shown.

Filed Form Detail Links
424B3 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 1.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.